Medical Cannabis Market to reach 20200 Mn US$ by 2025 at 24.4% CAGR to 2025 (BOL Pharma, Tilray, Medreleaf, Aurora Cannabis)

This report focuses on the global Medical Cannabis Market status, future forecast, growth opportunity, key market and key players. This information is extremely useful information for new and growing company to mark themselves over the market.

The Medical Cannabis Market is gaining traction all over the world because of a very high demand for marijuana among consumers and the legalization of medical cannabis in several countries. Medical conditions such as mental disorders, cancer, and chronic pain that are treated by using cannabis or marijuana are increasing rapidly.

Order a copy of Compounding Pharmacy Market 2019-2025 Report and Get Discount Upto 50% at

The need for medical marijuana is anticipated to increase manifold during the forecast period. The U.S. and Canada are legalizing and looking to support medical marijuana for both medical and recreational purposes. Products such as marijuana oil with increased safety and effectiveness are gaining traction, as compared to smoking medical marijuana.

The global Medical Cannabis market is valued at 3520 million US$ in 2018 is expected to reach 20200 million US$ by the end of 2025, growing at a CAGR of 24.4% during 2019-2025.

The report focuses on the global Medical Cannabis market status, future opportunities, growth analysis, key drivers and top players. The study objectives are to present the Medical Cannabis development in United States, Europe and China.

Medical Cannabis Market provides a detailed market overview of the industry including definitions, classifications, applications, challenges, competitive scenario and industry chain structure. The report also analysis the Medical Cannabis Market verticals and horizontals, Market Size and CAGR comparison by region.

The key players from Medical Cannabis market covered in this study are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc.

Medical Cannabis Market analysis done by Product types like Tetrahydrocannabinol (THC), Cannabidiol (CBD) and by Application like Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Others.It also provides analysis by Region such as United States, Europe, China, Japan, Southeast Asia, India, Central & South America.

The study objectives of this report are:
To analyze global Medical Cannabis status, future forecast, growth opportunity, key market and key players.
To present the Medical Cannabis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

Major Points from Table of Contents
1 Medical Cannabis Market Overview
2 Global Medical Cannabis Market Competition by Manufacturers
3 Global Medical Cannabis Production Market Share by Regions
4 Global Medical Cannabis Consumption by Regions
5 Global Medical Cannabis Production, Revenue, Price Trend by Type
6 Global Medical Cannabis Market Analysis by Applications
7 Company Profiles and Key Figures in Medical Cannabis Business
8 Medical Cannabis Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Medical Cannabis Market Forecast
12 Research Findings and Conclusion
13 Methodology and Data Source

Submit your details and specific interests for all customization needs Here

Contact Info:
Name: Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808

Release ID: 496108